AbbvieWorcester, MA, United States
Associate Director Precision Medicine
1489: Treatment with Upadacitinib in Patients with Systemic Lupus Erythematosus Results in the Inhibition of B-Cell–related Biomarkers: Analysis of the M19-130 (SLEek) Phase 2 Study
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.